Lucintel’s latest market report analyzed that immunoassay provides attractive opportunities in hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, and academic research centers. The immunoassay market is expected to grow at a CAGR of 5%-7%. In this market, reagents and kits are the largest segment by product and service, whereas hospitals are largest by end users.
Download Brochure of this report by clicking on https://www.lucintel.com/immunoassay-market.aspx
Based on product and service, the immunoassay market is segmented into reagents and kits, instruments, and services. The reagents and kits segment accounted for the largest share of the market in 2020 due to the requirement of repeat purchases of kits and reagents, increasing number of immunoassay tests, and rising incidence of chronic and infectious diseases.
Browse in-depth TOC on “Immunoassay Market”
XX – Tables
XX – Figures
The immunoassay market is marked by the presence of several big and small players. Some of the prominent players offering immunoassay include Roche, Abbott Laboratories, Siemens, Danaher Corporation, Sysmex Corporation, BioMérieux, Ortho Clinical Diagnostics, DiaSorin, QIAGEN, and Thermo Fisher Scientific.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link firstname.lastname@example.org.
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.